GPP
FOMX
Great Point Partners’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,110,071
| Closed | -$5.02M | – | 39 |
|
|
2019
Q2 | $5.02M | Sell |
2,110,071
-587,062
| -22% | -$1.4M | 0.56% | 19 |
|
|
2019
Q1 | $10.1M | Sell |
2,697,133
-1,350,428
| -33% | -$5.06M | 1% | 23 |
|
|
2018
Q4 | $14.5M | Buy |
4,047,561
+17,293
| +0.4% | +$62.1K | 1.84% | 17 |
|
|
2018
Q3 | $23.1M | Sell |
4,030,268
-751,440
| -16% | -$4.31M | 3.6% | 14 |
|
|
2018
Q2 | $24M | Hold |
4,781,708
| – | – | 3.32% | 12 |
|
|
2018
Q1 | $24.5M | Hold |
4,781,708
| – | – | 3.64% | 13 |
|
|
2017
Q4 | $28.7M | Hold |
4,781,708
| – | – | 4.9% | 8 |
|
|
2017
Q3 | $26.5M | Hold |
4,781,708
| – | – | 5.16% | 5 |
|
|
2017
Q2 | $22.2M | Buy |
4,781,708
+1,100,000
| +30% | +$5.1M | 3.97% | 10 |
|
|
2017
Q1 | $18.2M | Buy |
3,681,708
+681,708
| +23% | +$3.37M | 3.62% | 11 |
|
|
2016
Q4 | $33.3M | Buy |
3,000,000
+230,575
| +8% | +$2.56M | 6.84% | 2 |
|
|
2016
Q3 | $25.6M | Buy |
2,769,425
+2,494,669
| +908% | +$23.1M | 6.54% | 5 |
|
|
2016
Q2 | $1.75M | Buy |
+274,756
| New | +$1.75M | 0.5% | 25 |
|